Literature DB >> 10536123

Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.

R C Perkins1, V C Broaddus, S Shetty, S Hamilton, S Idell.   

Abstract

Inhalation of asbestos is associated with pathologic changes in the pleural space, including pleural thickening, pleural plaques, and mesothelioma. These processes are characterized by altered local proteolysis, cellular proliferation, and cell migration, suggesting that the urokinase-type plasminogen activator receptor (uPAR) could be involved in the pathogenesis of asbestos-induced pleural disease. We hypothesized that mesothelial cell uPAR expression is induced by exposure to asbestos. To test this hypothesis, we used complementary techniques in rabbit and human mesothelial cells to determine whether uPAR expression is altered by exposure to asbestos. uPAR expression was induced by chrysotile and crocidolite asbestos, but not by wollastonite, as indicated by binding of radiolabeled urokinase-type plasminogen activator (uPA) to rabbit or human mesothelial cells. uPA was not induced by fiber exposure. Exposure to exogenous uPA increased uPA activity of cells exposed to wollastonite but not asbestos-treated MeT5A cells. uPAR expression increased further when asbestos was preincubated with vitronectin (VN) or serum. Increases in uPAR expression were confirmed by binding of uPA to uPAR in cell membrane preparations and immunofluorescent staining of uPAR at the cell surface, and were associated with increases in steady-state uPAR messenger RNA. Mesothelial cell uPAR expression was also induced by media from monocytes cultured with asbestos incubated with VN and serum. By antibody neutralization, the latter effect appeared to be in part mediated by transforming growth factor-beta. We found that asbestos increases uPAR at the surface of rabbit and human mesothelial cells, suggesting that altered expression of this receptor could be involved in asbestos-induced remodeling of the pleural mesothelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536123     DOI: 10.1165/ajrcmb.21.5.3225

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

1.  Asbestos induces tissue factor in Beas-2B human lung bronchial epithelial cells in vitro.

Authors:  Alexei Iakhiaev; Usha Pendurthi; Steven Idell
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  A possible association between aprotinin and improved survival after radical surgery for mesothelioma.

Authors:  Peter H Norman; Peter F Thall; Ronaldo V Purugganan; Bernhard J C J Riedel; Dilip R Thakar; David C Rice; Lisa Huynh; Wei Qiao; Sijin Wen; W Roy Smythe
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

3.  Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines.

Authors:  Penny Nymark; Pamela M Lindholm; Mikko V Korpela; Leo Lahti; Salla Ruosaari; Samuel Kaski; Jaakko Hollmén; Sisko Anttila; Vuokko L Kinnula; Sakari Knuutila
Journal:  BMC Genomics       Date:  2007-03-01       Impact factor: 3.969

Review 4.  Mesothelial cells in tissue repair and fibrosis.

Authors:  Steven E Mutsaers; Kimberly Birnie; Sally Lansley; Sarah E Herrick; Chuan-Bian Lim; Cecilia M Prêle
Journal:  Front Pharmacol       Date:  2015-06-09       Impact factor: 5.810

Review 5.  HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis.

Authors:  Giovanni Gaudino; Haining Yang; Michele Carbone
Journal:  Biomedicines       Date:  2014-11-14

6.  Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.

Authors:  Shenqi Wang; Li Jiang; Yipeng Han; Shan Hwu Chew; Yuuki Ohara; Shinya Akatsuka; Liang Weng; Koji Kawaguchi; Takayuki Fukui; Yoshitaka Sekido; Kohei Yokoi; Shinya Toyokuni
Journal:  Oncotarget       Date:  2016-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.